source
- UK commission proposes new framework to regulate AI-driven medical toolsA UK commission released a report on Thursday outlining 44 recommendations for how artificial intelligence should be governed in the medical sector. The guidance aims to capture AI's promise, such…
- Tyra Biosciences’ bladder cancer pill misses expected response rate in Phase 2 trialShares of Tyra Biosciences dropped about 20% after data from its Phase 2 study of a bladder cancer pill fell short of market expectations. The experimental drug, dabogratinib, is taken daily and t…